Skip to Content

FluoroPharma Medical Inc FPMI

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

FPMI is trading at a 736% premium.
Price
$0.00
Fair Value
$5.49
Uncertainty
Extreme
1-Star Price
$8.46
5-Star Price
$5.92
Economic Moat
Lpxy
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if FPMI is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.02
Market Cap
$3,426.23
Volume/Avg
1,000 / 3,000

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

FluoroPharma Medical Inc is a US-based biopharmaceutical company. It specializes in developing and commercializing molecular imaging pharmaceuticals with initial applications in the area of cardiology. The company focuses on the development of novel cardiovascular imaging agents which detect and assess acute and chronic forms of coronary artery disease (CAD). The company’s clinical-stage molecular imaging pharmaceutical product candidates are 18-F TPP (BFPET) and 18-F FCPHA (CardioPET). The 18-F TPP is designed for use in stress-testing for patients with proven CAD whereas 18-F FCPHA is a molecular imaging agent which is designed to assess myocardial blood flow and metabolism in patients with CAD. The company operates in a single segment being Biopharmaceutical research and development.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Core
Total Number of Employees
4

Valuation

Metric
FPMI
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
FPMI
Quick Ratio
0.00
Current Ratio
0.00
Interest Coverage
−0.62
Quick Ratio
FPMI

Profitability

Metric
FPMI
Return on Assets (Normalized)
−610.54%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
FPMI
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Novo Nordisk A/S ADR
NVO
YvwyhsvnlJmqzb$631.5 Bil
Vertex Pharmaceuticals Inc
VRTX
KkswkysbPbpgq$121.0 Bil
Regeneron Pharmaceuticals Inc
REGN
NhhjcjmspBnzwkc$116.0 Bil
Moderna Inc
MRNA
WlqlslqbYwbd$51.1 Bil
argenx SE ADR
ARGX
ZsjwvddPxswk$23.7 Bil
Alnylam Pharmaceuticals Inc
ALNY
JqngnzlgNvdrd$21.0 Bil
BioNTech SE ADR
BNTX
DxrqtngxNlsym$20.4 Bil
Biomarin Pharmaceutical Inc
BMRN
ZmnhxmqXyqcqrs$15.9 Bil
United Therapeutics Corp
UTHR
PhchvqdwcCgqc$14.0 Bil
Incyte Corp
INCY
QykyvkxlbSjhnlq$12.5 Bil

Sponsor Center